Cargando…

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)

In the pediatric population, ischemic stroke is rare. Pediatric patients with acute ischemic stroke are eligible for intravenous thrombolysis and/or mechanical thrombectomy. However, due to the rare occurrence of strokes and national shortage of pediatric neurologists, timely diagnosis and appropria...

Descripción completa

Detalles Bibliográficos
Autores principales: Filatov, Asia, Alvarez, Jaime, Seibert, Jessica, Swerdloff, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431982/
https://www.ncbi.nlm.nih.gov/pubmed/34527475
http://dx.doi.org/10.7759/cureus.17088
_version_ 1783751058625921024
author Filatov, Asia
Alvarez, Jaime
Seibert, Jessica
Swerdloff, Marc
author_facet Filatov, Asia
Alvarez, Jaime
Seibert, Jessica
Swerdloff, Marc
author_sort Filatov, Asia
collection PubMed
description In the pediatric population, ischemic stroke is rare. Pediatric patients with acute ischemic stroke are eligible for intravenous thrombolysis and/or mechanical thrombectomy. However, due to the rare occurrence of strokes and national shortage of pediatric neurologists, timely diagnosis and appropriate treatment can be challenging. We report a case of a 16-year-old female who presented with an acute ischemic stroke to our adult comprehensive stroke program.
format Online
Article
Text
id pubmed-8431982
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84319822021-09-14 Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator) Filatov, Asia Alvarez, Jaime Seibert, Jessica Swerdloff, Marc Cureus Neurology In the pediatric population, ischemic stroke is rare. Pediatric patients with acute ischemic stroke are eligible for intravenous thrombolysis and/or mechanical thrombectomy. However, due to the rare occurrence of strokes and national shortage of pediatric neurologists, timely diagnosis and appropriate treatment can be challenging. We report a case of a 16-year-old female who presented with an acute ischemic stroke to our adult comprehensive stroke program. Cureus 2021-08-11 /pmc/articles/PMC8431982/ /pubmed/34527475 http://dx.doi.org/10.7759/cureus.17088 Text en Copyright © 2021, Filatov et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Filatov, Asia
Alvarez, Jaime
Seibert, Jessica
Swerdloff, Marc
Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title_full Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title_fullStr Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title_full_unstemmed Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title_short Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
title_sort management of pediatric strokes with alteplase (tissue plasminogen activator)
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431982/
https://www.ncbi.nlm.nih.gov/pubmed/34527475
http://dx.doi.org/10.7759/cureus.17088
work_keys_str_mv AT filatovasia managementofpediatricstrokeswithalteplasetissueplasminogenactivator
AT alvarezjaime managementofpediatricstrokeswithalteplasetissueplasminogenactivator
AT seibertjessica managementofpediatricstrokeswithalteplasetissueplasminogenactivator
AT swerdloffmarc managementofpediatricstrokeswithalteplasetissueplasminogenactivator